Market Performance - The Shanghai Composite Index and Shenzhen Component Index experienced declines of 0.30% and 0.69% respectively on May 5, 2025, while the ChiNext Index and STAR Market 50 fell by 0.87% and 1.96% respectively [1] - Among 33 A-share companies in Zibo, 30 saw an increase, 1 remained flat, and 2 declined during the same period [1] Notable Stock Movements - Weiming Pharmaceutical (002581) achieved a remarkable 23.29% increase over five days, leading the gains [1] - Yahua Electronics (301337) and Jincheng Pharmaceutical (300233) also saw significant increases of 17.30% and 11.31% respectively [1] - On May 7, PEEK material concept stocks surged, with Zhongxin Fluorine Materials (002915) hitting the daily limit for the sixth time in nine days, and Kaisheng New Materials (301069) rising by 2.29% with a trading volume of 4.02 billion yuan [1] Company Announcements - Kehui Co., Ltd. announced a share repurchase plan with a budget between 9 million and 16 million yuan, with a maximum repurchase price of 17 yuan per share, aimed at employee stock ownership plans [1] Financial Results - Furuida (600223) reported a revenue of 526 million yuan in its cosmetics segment for Q1 2025, with a gross margin of 61.06% [3] - Qichang Tenda (002408) achieved total revenue of 5.618 billion yuan in Q1 2025, a year-on-year increase of 2.53%, but saw a significant drop in net profit by 83.18% to 5.4007 million yuan [3] - Xinhua Medical (600587) reported a total revenue of 2.308 billion yuan, down 8.74% year-on-year, with a net profit decline of 23.97% to 160 million yuan [3] - Bohui Paper (600966) reported a total revenue of 4.564 billion yuan, a 3.77% increase year-on-year, but a net profit decline of 46.91% to 53.3737 million yuan [3] Market Capitalization - In terms of market capitalization, Yingke Medical (300677) led with 14.708 billion yuan, followed closely by Shandong Pharmaceutical Glass (600529) at 14.626 billion yuan, and Qichang Tenda (002408) at 12.963 billion yuan [4]

北京德和衡律师事务所 BEIJING DHH LAW FIRM 北京德和衡律师事务所 关于山东亚华电子股份有限公司 2024年年度股东大会的 法律意见书 德和衡证见意见（2025）第67号 中国·北京市朝阳区建国门外大街 2 号银泰中心 C 座 11、12 层 电话： (+86 10) 8540 7666 邮编：100022 www.deheheng.com 北京德和衡律师事务所 关于山东亚华电子股份有限公司 2024年年度股东大会的 法律意见书 德和衡证见意见（2025）第67号 本法律意见书仅供贵公司为本次股东大会之目的而使用，不得用于其他任何目的。本所律 师同意贵公司将本法律意见书随贵公司本次股东大会其他信息披露材料一并向公众披露，并依 法对本法律意见书承担相应责任。 本所律师根据对事实的了解以及对中国现行法律、法规和规范性文件的理解，按照律师行 业公认的业务标准、道德规范和勤勉尽责精神，现出具法律意见如下： 一、 本次股东大会的召集与召开程序 致：山东亚华电子股份有限公司 北京德和衡律师事务所（以下简称"本所"）接受山东亚华电子股份有限公司（以下简称 "公司"或"贵公司"）的委托，指派本所律师出席贵公 ...

证券代码：301337 证券简称：亚华电子 公告编号：2025-023 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时 间为：2025 年 5 月 9 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00；通 过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn）投票的具体时间为： 2025 年 5 月 9 日 9:15-15:00。 山东亚华电子股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、 本次股东大会不存在否决议案的情形。 2、 本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开情况 1、 召开时间： （1）现场会议召开时间：2025 年 5 月 9 日（星期五）14:00 2、 现场会议召开地点：淄博市高新区青龙山路 9509 号山东亚华电子股份有 限公司会议室 3、 召开方式：现场结合网络 4、 召集人：董事会 5、 主持人：董事长耿斌先生 6、 本次会议的召集、召开符合《中华人民共和国公司法 ...

Group 1: Company Performance - The company achieved a revenue of 218 million CNY in 2024, with a net profit attributable to shareholders of -26.49 million CNY [4] - In Q1 2025, the company reported a revenue of 39.57 million CNY, representing a year-on-year growth of 30.01%, while the net profit was -5.94 million CNY, a year-on-year increase of 28.00% [4] Group 2: Market and Policy Impact - Overseas market revenue accounted for 3.08% of total revenue in 2024, with products installed in over 40 countries, primarily in Southeast Asia [4] - The company is leveraging policy opportunities for the renovation of old hospital wards, with projects currently underway at several hospitals, including Shanghai First People's Hospital and Hainan Medical University [2] Group 3: Future Growth Drivers - The company focuses on the smart communication interaction system for hospitals, having served 80 top hospitals in China, and aims to enhance R&D capabilities to support smart hospital construction [4] - The rapid development of technologies such as artificial intelligence and the Internet of Things is being integrated into the company's third-generation ward interaction system, creating five typical application scenarios [4] Group 4: Industry Outlook - The digital healthcare and medical informationization sectors are becoming core topics in national policies, with increasing government support for domestic alternatives in the medical industry [5] - The implementation of the State Council's plan for large-scale equipment updates is expected to accelerate industry demand [5]

东吴证券股份有限公司 关于山东亚华电子股份有限公司 2024 年度持续督导跟踪报告 | 保荐人名称：东吴证券股份有限公司 | 被保荐公司简称：亚华电子 | | --- | --- | | 保荐代表人姓名：曹飞 | 联系电话：0512-62938583 | | 保荐代表人姓名：庞家兴 | 联系电话：0512-62938583 | 一、保荐工作概述 | 报告事项 | 说明 | | --- | --- | | 1.保荐代表人变更及其理由 | 无 | | 2.报告期内中国证监会和深圳证券交易所对保荐 | 报告期内不存在中国证监会和深交所对本项目发 | | 人或者其保荐的公司采取监管措施的事项及整改 | 行人或因本项目对保荐机构采取监管措施的事项 | | 情况 | 及整改情况。 | | 3.其他需要报告的重大事项 | 无 | （以下无正文） | （2）现场检查报告是否按照本所规定报送 | 是 | | --- | --- | | （3）现场检查发现的主要问题及整改情况 | 不适用 | | 6.发表专项意见情况 | | | （1）发表专项意见次数 | 8 次 | | （2）发表非同意意见所涉问题及结论意见 | 不适用 | ...

Overall Overview - In Q1 2025, the company achieved total operating revenue of 39.57 million yuan, a year-on-year increase of 30.01% [1] - The net profit attributable to the parent company was -5.94 million yuan, a year-on-year increase of 28.0% [1] - The net profit after deducting non-recurring gains and losses was -6.20 million yuan, a year-on-year increase of 29.65% [1] Profitability - The company's gross profit margin reached 40.38%, an increase of 22.34 percentage points year-on-year [2] - The net profit margin was -16.63%, an increase of 38.65 percentage points year-on-year, indicating improved cost control and higher added value of products or services [2] Expense Control - Total sales, management, and financial expenses amounted to 13.98 million yuan, accounting for 35.33% of operating revenue, a decrease of 12.34 percentage points compared to the same period last year [3] Cash Flow and Debt Situation - Operating cash flow per share improved from -0.27 yuan to -0.09 yuan, a year-on-year increase of 65.37%, but remained negative [4] - Cash and cash equivalents decreased from 732 million yuan to 517 million yuan, a reduction of 29.39% [4] - Interest-bearing debt decreased from 6.78 million yuan to 4.41 million yuan, a decrease of 34.90% [4] Other Key Indicators - Net asset per share decreased from 10.93 yuan to 10.52 yuan, a year-on-year decrease of 3.77% [5] - Earnings per share improved from -0.08 yuan to -0.06 yuan, a year-on-year increase of 25.00% [5]

证券代码：301337 证券简称：亚华电子 公告编号：2025-022 山东亚华电子股份有限公司 关于举办2024年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 山东亚华电子股份有限公司（以下简称"公司"）于2025年4月19日在巨潮资讯网 （www.cninfo.com.cn）披露了《2024年年度报告》及《2024年年度报告摘要》。为便 于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于2025年5 月8日（星期四）15:00-16:00在"价值在线"（www.ir-online.cn）平台举办公司 2024年度网上业绩说明会（以下简称"业绩说明会"），与投资者进行沟通和交流， 广泛听取投资者的意见和建议。现将有关事项公告如下： 一、业绩说明会召开的时间、地点和方式 召开时间：2025年5月8日（星期四）15:00-16:00 召开地点：价值在线（www.ir-online.cn） 召开方式：网络互动方式 二、业绩说明会出席人员 公司实控人、董事长耿斌先生，董事、总经理向晖女士，独立董事吴忠堂先生， 财务总监、董 ...

证券代码：301337 证券简称：亚华电子 公告编号：2025-021 山东亚华电子股份有限公司 关于2025年第一季度计提资产减值准备的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 山东亚华电子股份有限公司（以下简称"公司"）根据《企业会计准则》《深圳 证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第2号— —创业板上市公司规范运作》等相关规定的要求，基于谨慎性原则，为了更加真实、 准确的反映公司的资产与财务状况，公司及子公司于2025年第一季度末对应收款项、 存货、固定资产、在建工程等资产进行了全面清查，并对存在可能发生减值迹象的金 融资产在整个存续期内的预期信用损失、各类存货的可变现净值、固定资产、在建工 程等资产的可收回金额进行了充分的分析和评估，在此基础上对发生资产减值损失的 资产计提减值准备。经测算，2025年第一季度公司计提减值损失3,021,146.23元，具 体情况如下： | | 单位：元 | | --- | --- | | 1、信用减值损失 | -1,308,046.50 | | 其中：应收账款坏账损失 | -1 ...

Financial Performance - The company reported a basic earnings per share of -0.0600 yuan for Q1 2025, an improvement of 25% compared to -0.0800 yuan in Q1 2024, but a decline from 0.0500 yuan in Q1 2023 [1] - The net profit for Q1 2025 was -0.06 billion yuan, showing a 25% improvement from -0.08 billion yuan in Q1 2024, but a decrease from 0.04 billion yuan in Q1 2023 [1] - The operating revenue increased by 33.33% to 0.4 billion yuan in Q1 2025 from 0.3 billion yuan in Q1 2024, but decreased from 0.59 billion yuan in Q1 2023 [1] - The return on equity was -0.54% in Q1 2025, an improvement from -0.72% in Q1 2024, but a decline from 1.17% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 2.7582 million shares, accounting for 7.1% of the circulating shares, with a decrease of 1.2615 million shares compared to the previous period [1] - Notable changes in the top shareholders include the entry of Zhao Yongzhang, Chen Liping, and Chu Yazhou, while Sun Chengli, Zhou Lei, and Zhao Chen exited the top ten shareholders [2] Dividend Policy - The company has decided not to distribute dividends or transfer shares in this period [3]

Financial Performance - The company's operating revenue for Q1 2025 was ¥39,574,250.88, representing a 30.01% increase compared to ¥30,438,870.62 in the same period last year[5] - The net loss attributable to shareholders decreased to ¥5,941,587.31, a 28.00% improvement from a loss of ¥8,251,799.97 in the previous year[5] - Basic and diluted earnings per share improved to -¥0.06, up 25.00% from -¥0.08 in the same quarter last year[5] - Net profit for the period was a loss of ¥6,582,027.07, an improvement from a loss of ¥8,251,799.97 in the previous period[22] - The total comprehensive income attributable to the parent company was -6,140,104.12 yuan, an improvement from -8,251,799.97 yuan in the previous period, indicating a reduction in losses[23] Cash Flow - The net cash flow from operating activities improved significantly, with a net outflow of ¥9,825,237.73, a 65.37% reduction from ¥28,369,316.41 in Q1 2024[5] - Cash inflow from operating activities totaled 74,307,933.28 yuan, up from 63,277,518.24 yuan in the previous period, showing a growth of approximately 17.9%[24] - Cash outflow from investing activities was 250,612,304.32 yuan, compared to 227,454,109.37 yuan in the previous period, representing an increase of about 10.2%[25] - The net cash flow from investing activities was -248,838,477.36 yuan, worsening from -225,097,617.13 yuan in the previous period[25] - Cash inflow from financing activities was 2,147,000.00 yuan, with a net cash flow of 1,973,505.81 yuan, compared to a net outflow of -1,509,192.83 yuan in the previous period, indicating a turnaround[25] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥1,221,395,607.44, a slight decrease of 0.16% from ¥1,223,315,775.74 at the end of the previous year[5] - Current liabilities rose to ¥112,331,282.87, an increase of 3.1% from ¥109,076,183.95[20] - The company's total equity decreased to ¥1,096,463,133.51 from ¥1,103,243,500.54, reflecting a decline of 0.6%[20] - The company reported a significant increase in contract liabilities to ¥39,193,100.17, up 81.6% from ¥21,611,944.54[20] - The company's total liabilities decreased by 51.94% in accounts payable, reflecting a payment to suppliers[10] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,120[13] - The largest shareholder, Shenzhen Zhongya Huaxin Technology Co., Ltd., holds 46.30% of shares, totaling 48,240,000 shares[13] - The second-largest shareholder, Geng Yuquan, holds 8.26% with 8,609,500 shares[13] - The total number of restricted shares at the end of the period is 67,214,225, with no new restricted shares added during the period[16] - The company has a total of 48,240,000 shares under lock-up until May 26, 2026, for Shenzhen Zhongya Huaxin Technology Co., Ltd.[15] Operational Highlights - The company reported a significant increase in investment income, which rose by 58.24% to ¥277,883.63 compared to ¥175,608.04 in Q1 2024[10] - The company experienced a 451.66% increase in credit impairment losses, amounting to -¥1,308,046.50, primarily due to changes in the aging structure of accounts receivable[10] - The company recorded a significant increase in other operating income, which surged by 1,734.21% to ¥170,402.55, mainly due to increased penalty income[10] - Total operating costs increased to ¥45,994,635.44, up 6.0% from ¥43,257,625.18 in the previous period[21] - Research and development expenses were ¥7,801,866.82, a decrease of 21.4% compared to ¥9,923,001.88 in the previous period[21] Future Outlook - The company has not disclosed any new strategies or market expansions in the current reporting period[17] - There are no new products or technologies reported in the current financial call[17] - The company plans to implement new accounting standards starting in 2025, which may impact future financial reporting[26] - The company did not undergo an audit for the first quarter report, which may affect the perception of financial reliability[26]